Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,478.13
    -1,692.35 (-3.37%)
     
  • CMC Crypto 200

    1,259.41
    -98.60 (-7.26%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Horse racing-Kentucky Derby winner Medina Spirit clears final drug test for Preakness

(Reuters) - Kentucky Derby-winning horse Medina Spirit will compete in Saturday's Preakness Stakes after clearing pre-race drug tests, race organisers said on Friday.

The Bob Baffert-trained horse tested positive for the anti-inflammatory drug betamethasone after winning the first of the three famed Triple Crown races on May 1, raising questions over whether the three-year-old colt would be allowed to race at Pimlico Race Course.

Medina Spirit was cleared to compete after "undergoing three rounds of out-of-competition blood sample testing as part of the condition of entry," Pimlico owner Stronach Group said in a statement.

Baffert, one of the most recognizable figures in the world of professional horse racing with a record seven Kentucky Derby titles, said the prior failed drug test may have been due to the use of an anti-fungal ointment.

ADVERTISEMENT

On Tuesday he reached an agreement with Maryland state horse racing regulators that included "rigorous testing and monitoring" to allow him to compete.

(Reporting by Amy Tennery; Editing by Christian Radnedge)